Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aphria Inc. APHA

Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer


NDAQ:APHA - Post by User

Bullboard Posts
Post by jayjay2020on Jun 26, 2019 7:27pm
417 Views
Post# 29867502

Posted on another board

Posted on another board
in regards to Aleafia and APHA supply agreement. Looks like Aleafia is confident in APHA supplying them. "For your concern, Yesterday, a shareholder contact Aleafia Health team regarding the recent price drop of Aleafia stocks, and here is the respond letter he received from them. Hi Mason, Thanks for reaching out. As you know, the cannabis sector fluctuates a great deal on a day to day basis and this can be very frustrating for all our shareholders, and the team we have here. Due to regulatory rules, were also very limited in how we can communicate while we close the capital raise announced two weeks ago, which is expected to close on or about June 26, 2019. After that, we can continue to be extremely proactive in communicating with shareholders on the progress being made. The fundamentals of our business have only improved in recent weeks, with a successful capital raise and the game-changing outdoor cultivation licence. While the share price hasnt reflected that during this market-wide downturn, were confident that it will turn around. Moving forward, we believe we have important catalysts in 2019 as we really ramp up our cannabis cultivation and products across three facilities. Some of the important catalysts include: 160,000 sq. ft. Niagara Greenhouse 60,000 kg Port Perry Outdoor Grow 50,000 kg Extraction Capacity with Phase II Paris Expansion 175,000 kg, Five-Year Supply Agreement with Aphria" Aleafia Health - Investor & Media Relations Desk
Bullboard Posts